Tue, Jun 10, 3:42 PM (14 days ago)
**Resonate Blends, Inc. (KOAN) - Financial Summary** **Financial Performance (2024 vs. 2023):** - **Revenue:** $1,896,215 (2024) vs. $16,468 (2023) - **Net Income:** -$2,133,208 (2024) vs. -$1,415,979 (2023) - **Operating Expenses:** $2,933,817 (2024) vs. $301,551 (2023) - **Earnings per Share:** -$0.02 (2024 & 2023) **Strategic Overview:** - Focus on regenerative medicine and natural stem cell mobilizing agents. - Acquisition of Emergent Health Corp. (EMGE) and related restructuring. - Change in control with new CEO James W. Zimbler. **Future Outlook:** - Uncertain due to substantial doubt about the ability to continue as a going concern. - Dependent on additional financing and achieving profitable operations. **Risk Factors:** - Substantial doubt about the ability to continue as a going concern. - History of losses and potential for future losses. - Dependence on additional investment capital. **Financial Condition:** - **Total Assets:** $1,854,461 (2024) vs. $992,341 (2023) - **Total Liabilities:** $5,054,040 (2024) vs. $3,127,913 (2023) - **Working Capital Deficit:** $3,513,398 (2024) vs. $2,150,975 (2023) - **Accumulated Deficit:** $28,869,611 (2024) vs. $26,736,403 (2023) **Market Position Changes:** - Quoted on OTCQB under the symbol "KOAN." - Limited market with no assurance of a regular trading market. **Key Financial Ratios (2024):** - **Current Ratio:** 0.20 (Current Assets / Current Liabilities) - **Debt to Equity Ratio:** -2.72 (Total Liabilities / Total Equity) **Management and Governance:** - New CEO James W. Zimbler appointed on March 5, 2025. - Board of Directors includes Jay Lucas, Robert Carpenter, and Lance Liberti. **Cybersecurity:** - No material cybersecurity events reported. - Continuous assessment and strengthening of cybersecurity program. **Auditor's Opinion:** - Substantial doubt about the company's ability to continue as a going concern. - Financial statements fairly present the company's financial position and results of operations.